Cassava Sciences (SAVA) Financials

$1.21

$-0.08 (-6.23%)

As on 12-May-2026 09:30EDT

Market cap

$115 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.84	--	--	--	0.00	--
Cost of Revenue	-13.42	0.94	1.13	89.42	1.30	0.53
Gross Profit	13.42	-0.94	-1.13	-89.42	0.00	-0.53
Operating Expenses	95.40	94.45	141.45	16.53	80.02	32.87
Operating Profit (EBIT)	-81.97	-95.39	-141.45	-105.96	-80.02	-32.87
Other Income	--	--	--	--	--	0.48
Profit before Tax	-77.90	-90.97	-24.34	-97.22	-76.25	-32.39
Provision for Tax	--	--	--	--	-3.77	-0.58
Profit after Tax (Net Income)	-77.90	-90.97	-24.34	-97.22	-72.47	-31.80
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-76.25	-32.39

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	68.14	74.40	145.70	137.47	227.54	253.92
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.11	0.12	0.08	--	0.23	0.33
Current Liabilities	40.12	43.83	11.75	14.20	7.06	12.53
Total Liabilities	148.48	118.36	157.53	151.66	234.83	266.78

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	20.40	20.65	21.00	22.03	23.61	22.30
Current Assets	87.96	97.71	136.53	129.63	211.23	244.48
Total Assets	196.33	118.36	157.53	151.66	234.83	266.78
Total Debt*	--	--	--	--	0.14	0.24
Net Current Assets	--	53.88	124.78	115.44	204.16	231.95

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-32.25	-116.93	-82.03	-77.51	-30.20
Cash Flow from Investing Activities	--	-0.58	-0.10	-0.41	-2.71	-22.21
Cash from Financing Activities	--	-0.24	124.47	2.56	47.80	192.34
Net Cash Inflow / Outflow	--	--	--	--	--	139.93

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.61	-1.88	-0.51	-2.30	-1.78	-0.80
Cash EPS ($)	--	-1.86	-0.48	-2.27	-1.75	-0.78
Adjusted Book Value ($)	--	1.54	3.03	3.26	5.58	6.35
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.67	-2.43	-1.94	-1.90	-0.76
Free Cash Flow per Share ($)	--	-0.68	-2.43	-1.95	-1.97	-1.31

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-82.66	-17.19	-53.25	-30.08	-18.35
ROE (%)	-104.07	-82.66	-17.19	-53.27	-30.11	-18.38
ROA (%)	-44.45	-65.95	-15.75	-50.31	-28.90	-17.61
EBIT Margin (%)	-10,115.71	--	--	--	4,445,555.56	--
Net Margin (%)	-9,273.93	--	--	--	4,026,222.22	-6,584.27
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-31.26	--	--	1.00	--	--
EBIT Growth (%)	39.35	32.96	-34.28	-32.41	-143.46	-383.92
Net Profit Growth (%)	-7.02	-273.73	74.96	-34.14	-127.89	-402.08
EPS Growth (%)	-6.96	-2.72	0.78	-0.30	-1.23	-2.79
Book Value Growth (%)	-46.64	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.05	-4.66	-9.77	-16.62	-54.91
Price / Book Value	0.92	1.29	0.78	6.91	5.29	6.88
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.08	0.00	0.11	-7.93	-12.75	-46.79
Close Price ($)	1.69	1.98	2.36	22.51	29.54	43.70
High Price ($)	4.98	4.98	42.20	38.53	62.49	146.16
Low Price ($)	1.15	1.15	2.23	12.32	13.84	6.78
Market Cap ($ Cr)	114.97	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	0.00	0.00
Short term debt to equity ratio	--	--	--	--	0.00	0.00
Current Ratio	2.19	2.23	11.62	9.13	29.91	19.51
Quick Ratio	2.19	--	--	--	--	--
Interest Coverage	--	--	--	--	-21.20	-68.05

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	13.93	--	--	--	--	--
Asset Turnover	0.00	--	--	--	0.00	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	9,619.23	2,940.55	29.80	1,564.17	2,748.61
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.